Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus

Design and development of an effective drug to combat the 2019 novel coronavirus remains a challenge. Therefore, it is of interest to study the binding features of 1615 FDA approved drugs with the recently known 2019-nCoV main protease structure having high sequence homology with that from SARS-CoV....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioinformation
Hauptverfasser: Odhar, Hasanain Abdulhameed, Ahjel, Salam Waheed, Albeer, Ali A.Mohammed Ali, Hashim, Ahmed Fadhil, Rayshan, Ali Mahmood, Humadi, Suhad Sami
Format: Artigo
Sprache:Inglês
Veröffentlicht: Biomedical Informatics 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147498/
https://ncbi.nlm.nih.gov/pubmed/32308266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630016236
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge